Company / EPS (Diluted)
CME Group EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$11.16
FY2025
5-year range
$7.29 / $11.16
FY2021-FY2025
Trend
+15.4%
vs FY2024
Sector context
#36 of 387
Financials
What the data says
Among 387 Financials companies, CME Group is in the top 9% for eps (diluted). EPS (Diluted) has increased for 5 consecutive years, from $5.71 in FY2020 to $11.16 in FY2025.
Based on SEC 10-K filings.
11.16 in FY2025 with a 5-year CAGR of +14.3%. Top quartile in the Financials sector.
Improved from $8.86 to $11.16 over the past 2 years.
Financials sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +14.7%
- 5-Year CAGR
- +14.3%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in FinancialsTop 9% of 387This company $11.16 Sector average $6.48
▼
+72.2% above sector average
Key checks
Key Insights
- CME Group's eps (diluted) has grown for 5 consecutive years.
- In FY2025, eps (diluted) increased 15.4% year-over-year.
- Ranks #36 out of 387 companies in the Financials sector.
- Peak eps (diluted) was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.22 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.16 | +15.4% |
| FY2024 | $9.67 | +9.1% |
| FY2023 | $8.86 | +19.7% |
| FY2022 | $7.40 | +1.5% |
| FY2021 | $7.29 | +27.7% |
| FY2020 | $5.71 | -52.2% |
| FY2019 | $11.94 | +109.1% |
| FY2018 | $5.71 | -52.2% |
| FY2017 | $11.94 | +163.6% |
| FY2016 | $4.53 | +55.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026